div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentcceoe-oeeoecc-nasonex-section-262-pharmacologyhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: 独立行政法人 医薬品医療機器総合機構NASONEX Section 262 Pharmacology Written Summary 2626132 MF 262-22 UÏC T T lgE O GM-CSF IL-5 L T B 4 PA F eotaxin loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsnetreader033viewer20220519156006bbbf6c411f443f74e1bchtml5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentcceoe-oeeoecc-nasonex-section-262-pharmacologyhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: 独立行政法人 医薬品医療機器総合機構NASONEX Section 262 Pharmacology Written Summary 2626132 MF 262-22 UÏC T T lgE O GM-CSF IL-5 L T B 4 PA F eotaxin loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsnetreader033viewer20220519156006bbbf6c411f443f74e1bchtml5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentcceoe-oeeoecc-nasonex-section-262-pharmacologyhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: 独立行政法人 医薬品医療機器総合機構NASONEX Section 262 Pharmacology Written Summary 2626132 MF 262-22 UÏC T T lgE O GM-CSF IL-5 L T B 4 PA F eotaxin loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsnetreader033viewer20220519156006bbbf6c411f443f74e1bchtml5thumbnails3jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=4Page 4button...